- Projects & figures
- News & Events
- Managing your project
- About ERC
Water vapour has been detected in the atmosphere of a remote planet with habitable temperatures. Two ERC grantees at the University College London (UCL) were among the coauthors of study.
On a clear summer night, look up to the sky and what do you see? Ordinary matter such as planets, stars maybe even an asteroid. Millions of little specks, as far as the eyes can reach. This ordinary matter, also known as baryonic matter, is the primary observable component of our universe. But is what we see all that is out there?
Diseases affecting the retina cause one quarter of worldwide blindness. To date, there are no treatments to restore lost retinal cells and visual function, making it urgent to find new therapeutic approaches. Can stem cells be the solution? Prof. Majlinda Lako aims at growing artificial replicas of the human retina using stem cells.
ELECTION SERIES #3
The traditional pencil-and-paper method to mark your vote in the polling booth has been gradually replaced by electronic voting machines in many countries, in Europe and beyond. Ensuring the security of electronic voting machines and quelling fears of vote-rigging have become ever more important. One ERC-funded researcher has been working tirelessly to develop such an e-voting system through two projects, SEEVS and its follow-up SEEVCA.
The increasing development of wearable technology sparks the need for new, innovative ways to interact with our shiny gadgets. Deviating from the conventional approach based on touch-sensitive devices, Prof. Jürgen Steimle aims at producing body-worn user interfaces that can be applied directly on the skin. Highly personalised, biocompatible and ultrathin, these devices will seamlessly blend with the human skin to create a technological extension of our body.
Key nutrients can improve vision both in ageing and in healthy eyes, according to EU-funded research. Doctors are now prescribing supplements of these nutrients, while the researchers are investigating other possible health benefits.
An EU-funded project is exploring what keeps people committed to a task even when they get bored, distracted or are tempted to stop. The findings could foster productivity-boosting strategies, improve robot-human interactions and even help treat borderline personality disorder.
The amount of currently available biomedical data is overwhelming. Large databases exist at different scales, from genes, to proteins, to patients' histories. But what do scientists do with all this information? Serbian-born Professor Nataša Pržulj, from University College London, works with Big Data to establish patterns and gain knowledge that could revolutionise how we treat diseases.
At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.
More than 100 million people worldwide suffer from valvular heart disease, affecting one or more of the heart’s four valves and causing breathlessness, chest pain, dizziness and fainting. If severe valvular heart disease is not properly treated, chances of surviving decrease, especially in the elderly. The only effective therapy is heart valve replacement, which may entail some risks and lead to revision surgeries. What can be done to improve safety and durability of artificial heart valves?